ClinicalTrials.gov record
Completed Phase 3 Interventional

OVATURE (OVArian TUmor REsponse) A Phase III Study of Weekly Carboplatin With and Without Phenoxodiol in Patients With Platinum-Resistant, Recurrent Epithelial Ovarian Cancer

ClinicalTrials.gov ID: NCT00382811

Public ClinicalTrials.gov record NCT00382811. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 18, 2026, 4:57 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Multi-Center, Randomized, Double-Blind, Phase III Efficacy Study Comparing Phenoxodiol in Combination With Carboplatin Versus Carboplatin With Placebo in Patients With Platinum-Resistant or Platinum-Refractory Late-Stage Epithelial Ovarian, Fallopian or Primary Peritoneal Cancer Following at Least Second Line Platinum Therapy

Study identification

NCT ID
NCT00382811
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
MEI Pharma, Inc.
Industry
Enrollment
142 participants

Conditions and interventions

Interventions

  • carboplatin Drug
  • phenoxodiol Drug
  • placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 30, 2006
Primary completion
Mar 31, 2009
Completion
Mar 31, 2011
Last update posted
Jul 17, 2016

2006 – 2011

United States locations

U.S. sites
37
U.S. states
18
U.S. cities
35
Facility City State ZIP Site status
Arizona Clinical Research Center, Inc. Tuscon Arizona 85715
Glendale Adventist Glendale California 91206
Kaiser Permanente Los Angeles Medical Center Los Angeles California 90027
Cedars-Sinai Medical Center Los Angeles California 90048
Gynecology Oncology Associates Newport Beach California 92663
Yale University School of Medicine New Haven Connecticut 06520
Hematology Oncology, PC (Carl and Dorothy Bennett Cancer Center) Stamford Connecticut 06902
Gynecologic Oncology Associates Pembroke Pines Florida 33028
Piedmont Hospital Atlanta Georgia 30309
Medical College of Georgia Cancer Center Augusta Georgia 30912
Associates in Women's Health Wichita Kansas 67214
Hematology and Oncology Specialists, LLC Metairie Louisiana 70006
Greater Baltimore Medical Centre Baltimore Maryland 21204
Gynecologic Oncology of West Michigan Grand Rapids Michigan 49546
Providence Hospital and Medical Centers Southfield Michigan 48075
The Center for Cancer & Hematological Disease Cherry Hill New Jersey 08003
Jersey Shore Medical Center Neptune City New Jersey 07754
The University of New Mexico Cancer Research and Treatment Center Albuquerque New Mexico 87131-0001
Schwartz Gynecologic Oncology Brightwaters New York 11718
New York Downtown Hospital New York New York 10038
University of Rochester Gynecologic Oncology Associates Rochester New York 14620
Carolinas Medical Center Charlotte North Carolina 28204
Brody School of Medical at East Carolina University Greenville North Carolina 27834
Wake Forest University Health Sciences Winston-Salem North Carolina 27157
Gabrail Cancer Center Canton Ohio 44718
MetroHealth Medical Center Cleveland Ohio 44109
OSU James Cancer Hospital & Solove Research Institute Columbus Ohio 43210
Miami Valley Hospital Dayton Ohio
Chattanooga GYN Oncology Chattanooga Tennessee 37403
Chattanooga's Program In Women's Oncology Chattanooga Tennessee 37403
Hall and Martin MDS, P.C. Knoxville Tennessee 37920
Sarah Cannon Research Institute Nashville Tennessee 37203
Hope Cancer Clinic Brownsville Texas 78526
University of Texas Southwestern Medical Center Simmons Comprehensive Cancer Center Dallas Texas 75390
Baylor College of Medicine Houston Texas 77030
Northern Virginia Pelvic Surgery Associates Annadale Virginia 22003
Virginia Mason Medical Center Department of Hematology/Oncology Seattle Washington 98101

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 33 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00382811, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 17, 2016 · Synced May 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00382811 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →